← Open Payments lookup

MEGAN TYNDALL: Open Payments

NPI 1861915779 · BERLIN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$516 in 21 payments from 10 companies in 2025. Trend: 2023 $140 · 2024 $247 · 2025 $516

Food & beverage: $516
CompanyPaymentsAmount
Actelion Pharmaceuticals US, Inc.1$125
Phathom Pharmaceuticals, Inc.5$83
ABBVIE INC.3$61
Merck Sharp & Dohme LLC2$50
Sumitomo Pharma America, Inc.2$40
Astellas Pharma US Inc2$40
Novo Nordisk Inc2$39
Aimmune Therapeutics, Inc.1$34
Lilly USA, LLC2$31
Bayer Healthcare Pharmaceuticals Inc.1$14

Products named: UPTRAVI, VOQUEZNA, GARDASIL 9, UBRELVY, GEMTESA, Veozah, VOWST, Wegovy.

Industry payments across MD — which companies pay providers there.